WebThe current standard-of-care therapy for unresected locally advanced squamous cell carcinoma of the head and neck is high-dose cisplatin-based chemoradiotherapy. 6. NCCN Clinical Practice Guidelines in Oncology ... Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head ... WebCisplatin, Radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma. Keys HM et al. N Engl J Med (1999); 340: 1154 ... weekly cisplatin for locally advanced head and neck cancer. Head Neck 2005;27:36-43. 8. Medina JA, Rueda A, de Pasos AS, et al. A phase II study of …
Considerations for older adults with head and neck cancer CIA
WebJun 28, 2024 · According to results from two clinical trials published in The New England Journal of Medicine, the addition of the chemotherapy agent cisplatin (Platinol®) to … WebJun 4, 2024 · Patil VM, Noronha V, Menon NS, et al. Results of phase 3 randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer unsuitable for cisplatin-based ... canning fully cooked chicken
Randomized phase III trial of concurrent accelerated radiation plus ...
WebFeb 16, 2016 · Conclusions: In head and neck cancer patients, nephrotoxicity grade 2 is under-reported but is the major factor for discontinuing cisplatin during CCRT. Purpose: … WebThe Radiation Therapy Oncology Group launched a phase III trial to test the hypothesis that adding cetuximab to the radiation-cisplatin platform improves progression-free survival … WebChemotherapy consisted primarily of cisplatin and 5-FU at two dose levels in our institution. 25 One comprised cisplatin 12 mg/m 2 plus 5-FU 600 mg/m 2 per day administered as … fix the mask